Leishmaniasis clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Sorry, not accepting new patients
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
San Francisco, California
Our lead scientists for Leishmaniasis research studies include Brian Schwartz.
Last updated: